HR Execs on the Move

North Central Connecticut EMS Council Inc

www.northcentralctems.org

 
North Central Connecticut EMS Council Inc is a Hartford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Live Better Hearing

Live Better Hearing + Balance is a premier audiology practice with locations throughout the Mid Atlantic. They provide a full range of audiology services for all ages with appropriate, medically & scientifically sound testing & treatment options.

Strawn Arnold

Strawn Arnold & Associates, Ltd.. is a premier provider of executive search to the healthcare industry. Our reputation has been built through executing searches for directors of governance boards, all levels of general management, as well as selected functional experts. Many of our Partners are recognized as "best in class" in their market segments. With nearly four decades of service and experience, Strawn Arnold & Associates, Ltd. is unparalleled in the depth of its knowledge and understanding of the healthcare market. Our firm stands for results, integrity and personal service, while providing access to business leaders at the highest level across the industry.

Aventine HealthSciences

Aventine HealthSciences is a Montclair, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reperio

Reperio Health is a company that offers at-home biometric health screenings with instant results and 24/7 live support.

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.